|
 |
|
 |
|
 |
| |
 |
 |
| Investors - Corporate Governance |
 |
The provisions of the Listing agreements to be entered into with the Stock Exchanges with respect to corporate governance and the SEBI Rules and Regulations in respect of corporate governance are applicable to our Company at the time of seeking in-principle approval of the Stock Exchanges. Our Company has taken steps to comply with such provisions, as 8 contained in the Listing Agreement, particularly those relating to composition of Board of Directors, constitution of committees such as audit committee, shareholder / investor grievance committee, etc. Further, our Company undertakes to take all necessary steps to comply with all the requirements of the regulations on corporate governance and adopt the corporate governance code as per Clause 49 of the Listing Agreement to be entered into with the Stock Exchanges.
|
| |
Various Committees of Directors |
| |
| In terms of the Clause 49 of the Listing Agreement, our Company has already appointed Independent Directors and constituted the following Committees of the Board : |
| |
- Audit Committee
- Shareholders/ Investor Grievance Committee
- Remuneration Committee
- IPO Committee
|
| Audit Committee |
| |
Our Board constituted an Audit Committee, pursuant to the provisions of Section 292A of the Companies Act. The Audit Committee was reconstituted vide the Board resolution dated August 11, 2010.
The terms of reference of Audit Committee comply with the requirements of Clause 49 of the Listing Agreement. Currently the Audit Committee comprises of |
| |
| |
Name of the Director |
Designation in the Committee |
Nature of Directorship |
 |
Mr.Balkrishna R. Parab |
Chairman |
Non Executive and Independent Director |
 |
Dr. Ullooppee S. Badade |
Member |
Non Executive and Independent Director |
 |
Dr. Kannan K. Vishwanath |
Member |
Executive and Non Independent Director |
|
|
| |
Mr. Yogesh Patel, our Company Secretary will act as the secretary to the Committee.
The Audit Committee enjoys following powers:
-
To invite such of the executives, as it considers appropriate (and particularly the head of finance function) to be present at the meetings of the Committee,
-
To investigate any activity within its terms of reference;
-
To seek information from any employee;
-
To obtain outside legal or other professional advice; and
-
To secure attendance of outsiders with reasonable expertise, if considered necessary.
The terms of reference of the Audit Committee of our Company includes:
-
Overseeing our Company’s financial reporting process and the disclosure of its financial information to ensure that the financial statement is correct, sufficient and credible.
-
Recommending to the Board, the appointment, re-appointment and, if required, the replacement or removal of the statutory auditor and the fixation of audit fees.
-
Approval of payment to statutory auditors for any other services rendered by the statutory auditors.
-
Appointment, removal and terms of remuneration of internal auditors
-
Reviewing, with the management, the annual financial statements before submission to the Board for approval, with particular reference to:
- Matters required to be included in the Director’s Responsibility Statement to be included in the Board’s report in terms of clause (2AA) of Section 217 of the Companies Act 1956;
- Changes, if any, in accounting policies and practices and reasons for the same;
- Major accounting entries involving estimates based on the exercise of judgment by management;
- Significant adjustments made in the financial statements arising out of audit findings;
- Compliance with listing and other legal requirements relating to the financial statements;
- Disclosure of any related party transactions;
- Qualifications in the draft audit report;
-
Reviewing, with the management, the quarterly, half-yearly and annual financial statements before submission to the Board for approval;
-
Reviewing, with the management, the statement of uses / application of funds raised through an issue (public issue, rights issue, preferential issue, etc.), the statement of funds utilized for purposes other than those stated in the offer document/prospectus/notice and the report submitted by the monitoring agency monitoring the utilisation of proceeds of a public or rights issue, and making appropriate recommendations to the Board to take up steps in this matter;
-
Monitoring the use of the proceeds of the proposed initial public offering of our Company.
- Reviewing, with the management, performance of statutory and internal auditors, and adequacy of the internal control systems;
- Reviewing the adequacy of internal audit function, if any, including the structure of the internal audit department, staffing and seniority of the official heading the department, reporting structure, coverage and frequency of internal audit;
-
Reviewing management letters / letters of internal control weaknesses issued by the statutory auditors;
-
Discussion with internal and statutory auditors on any significant findings and follow up there on;
-
Reviewing the findings of any internal investigations by the internal auditors into matters where there is suspected fraud or irregularity or a failure of internal control systems of a material nature and reporting the matter to the Board;
-
Discussion with the statutory auditors before the audit commences, about the nature and scope of audit as well as post-audit discussion to ascertain any area of concern;
-
To look into the reasons for substantial defaults in the payment to the depositors, debenture holders, shareholders (in case of nonpayment of declared dividends) and creditors;
-
To review the functioning of the Whistle Blower mechanism, when the same is adopted by our Company and is existing;
-
Carrying out any other function as may be statutorily required to be carried out by the Audit Committee;
-
The Audit Committee shall mandatory review the following information:
- Management discussion and analysis of financial condition and results of operations;
- Statement of significant related party transactions (as defined by the audit committee), submitted by management;
- Management letters / letters of internal control weaknesses issued by the statutory auditors;
- Internal audit reports relating to internal control weaknesses; and
- The appointment, removal and terms of remuneration of the Chief internal auditor shall be subject to review by the Audit Committee.
- Financial statements, in particular, the investments made by the unlisted subsidiary company
|
The recommendations of the Audit Committee on any matter relating to financial management, including the audit report, are binding on the Board. If the Board is not in agreement with the recommendations of the Committee, reasons for disagreement shall have to be minuted in the Board Meeting and the same has to be communicated to the shareholders. The Chairman of the committee has to attend the Annual General Meetings of our Company to provide clarifications on matters relating to the audit. |
| |
| Shareholders / Investors Grievance Committee |
| |
Our Company has constituted a Shareholders’ / Investors’ Grievance Committee vide resolution dated April 20, 2010, as per the requirements of the Clause 49 of the Listing Agreement for Corporate Governance, for redressing Shareholder / Investor complaints. Currently the Shareholders / Investors Grievance Committee comprises of: |
| |
| |
Name of the Director |
Designation in the Committee |
Nature of Directorship |
 |
Dr. Ullooppee S. Badade |
Chairman |
Non Executive and Independent Director |
 |
Mr. Giridhar G. Pulleti |
Member |
Non Executive and Independent Director |
 |
Dr. Kannan K. Vishwanath |
Member |
Executive and Non Independent Director |
|
|
| |
Mr. Yogesh Patel, our Company Secretary will act as the Secretary to the Committee.
The Shareholders / Investors Grievance Committee is responsible for the redressal of shareholders and investors’ grievances and oversees performance of the registrars and transfer agents of our Company and recommends measures for overall improvement in the quality of investor services. This committee also monitors the implementation and compliance of our Code of Conduct for Prohibition of Insider Trading pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, as amended. in compliance of the provisions of Clause 49 of the listing agreements with the Stock Exchanges and its terms of reference include the following: |
| |
| The terms of reference include the following: |
| |
-
Efficient transfer of Equity Shares; including review of cases for refusal of transfer / transmission of shares and debentures;
-
Redressing of shareholders and investor complaints such as non-receipt of declared dividend, annual report, transfer of Equity Shares and issue of duplicate/split/consolidated share certificates;
-
Monitoring transfers, transmissions, dematerialization, re-materialization, splitting and consolidation of Equity Shares and other securities issued by our Company, including review of cases for refusal of transfer/ transmission of shares and debentures;
-
Allotment and listing of shares in future;
-
Review of cases for refusal of transfer / transmission of shares and debentures;
-
Reference to statutory and regulatory authorities regarding investor grievances;
-
Ensure proper and timely attendance and redressal of investor queries and grievances;
-
To do all such acts, things or deeds as may be necessary or incidental to the exercise of the above powers;
-
To review from time to time the secretarial department;
-
Investor relations and redressal of shareholders grievances in general and relating to non receipt of declared dividends, interest, non- receipt of balance sheet etc.;
|
Such other matters as may from time to time be required by any statutory, contractual or other regulatory requirements to be attended to by such committee. |
| |
| Remuneration Committee |
| |
For remuneration of Directors, our Company has constituted Remuneration Committee vide Board resolution dated April 20, 2010. The Committee has powers of recommending remuneration package to for Executive Directors and other Board members as per the requirements of the Clause 49 of the Listing Agreement for corporate governance. Currently the remuneration committee comprises of: |
| |
| |
Name of the Director |
Designation in the Committee |
Nature of Directorship |
 |
Mr. Balkrishna R. Parab |
Chairman |
Non Executive and Independent Director |
 |
Mr. Giridhar G. Pulleti |
Member |
Non Executive and Independent Director |
 |
Dr. Ullooppee S. Badade |
Member |
Executive and Non Independent Director |
|
|
| |
Mr. Yogesh Patel, our Company Secretary will act as the secretary to the committee. |
| |
| The terms of reference of the remuneration committee of our Company includes: |
| |
-
Framing suitable policies and systems to ensure that there is no violation, by an employee of any applicable laws in India, including:
- The Securities and Exchange Board of India (Insider Trading) Regulations, 1992; or
- The Securities and Exchange Board of India (Prohibition of Fraudulent and Unfair Trade Practices relating to the Securities Market) Regulations, 1995.
-
To recommend to the Board, the remuneration packages of our Company’s Managing/Joint Managing/ Deputy Managing/Whole time / Executive Directors, including all elements of remuneration package (i.e. salary, benefits, bonuses, perquisites, commission, incentives, stock options, pension, retirement benefits, details of fixed component and performance linked incentives along with the performance criteria, service contracts, notice period, severance fees etc.);
-
To be authorised at its duly constituted meeting to determine on behalf of the Board of Directors and on behalf of the shareholders with agreed terms of reference, our Company’s policy on specific remuneration packages for Company’s Managing/Joint Managing/ Deputy Managing/ Whole Time/ Executive Directors, including pension rights and any compensation payment;
-
Perform such functions as are required to be performed by the Remuneration Committee under the ESOP Guidelines, in particular, those stated in Clause 5 of the ESOP Guidelines; and
-
To implement, supervise and administer any share or stock option scheme of our Company
-
To attend to any other responsibility as may be entrusted by the Board within the terms of reference.
-
Such other matters as may, from time to time, be required by any statutory, contractual or other regulatory requirements to be attended to by such committee.
|
| |
| IPO Committee |
| |
The IPO committee was constituted vide Board Resolution dated June 01, 2010 to oversee and inform the audit committee when money is raised through the prospectus or rights or preferential issues and shall inform of funds received, utilized, pending for project implementation etc. for the information of the Stock Exchanges and Investors and shall keep the information up dated through our Company’s website. |
| |
| The composition of the IPO committee is as follows: |
| |
| |
Name of the Director |
Designation in the Committee |
Nature of Directorship |
 |
Dr. Kannan K. Vishwanath |
Chairman |
Executive and Non Independent Director |
 |
Mr. Kashi Vishwanathan |
Member |
Executive and Non Independent Director |
 |
Mr. Prabhat K. Goyal |
Member |
Executive and Non Independent Director |
|
|
| |
| The terms of reference of the IPO committee are as follows: |
| |
-
to decide on the actual size of the IPO, including any offer for sale by promoters/shareholders, green shoe option, any pre-IPO placement, promoter’s contribution and/or reservation for employees or shareholders of promoting companies or shareholders of group companies and/or any other reservations or firm allotments as may be permitted, timing, pricing and all the terms and conditions of the issue of the Equity Shares, and to accept, implement, negotiate, carry out and decide any amendments, modifications, variations or alterations thereto;
-
to appoint and enter into arrangements with the book running lead managers, co-mangers to the Issue, underwriters to the Issue, bankers to our Company, syndicate members to the Issue, advisors to the Issue, stabilizing agent, brokers to the Issue, escrow collection bankers, accountants, auditors, depositories, trustees, custodians, registrar to the Issue, legal advisors as to Indian and overseas jurisdictions to our Company, advertising and/or promotion or public relations agencies and any other agencies, persons or other intermediaries as may be involved with the IPO, including any successors or replacements thereof;
-
to finalize, approve, execute and deliver or arrange the delivery of the offering documents (including the draft red herring prospectus, the red herring prospectus, the final prospectus (including the preliminary international wrap and the final international wrap, if required, for marketing of the Issue in jurisdictions outside India)), the statement-in-lieu of the prospectus, syndicate agreement, underwriting agreement, escrow agreement, stabilization agreement and all other documents, deeds, agreements and instruments and any amendments, supplements, notices or corrigenda thereto, together with any summaries thereto, as may be required or desirable in connection with the issue of the Equity Shares or the IPO by our Company;
-
to open one or more separate current account(s) in such name and style as may be decided, with a scheduled bank to receive applications along with application monies in respect of the issue of the Equity Shares of our Company;
-
to open one or more bank account(s) of our Company in such name and style as may be decided for the handling of refunds for the Issue;
-
to open any other bank account(s), share/securities account, escrow or custodian accounts, in India or abroad, in rupees or in any other currency, in accordance with applicable laws, rules, regulations, approvals and guidelines;
-
to make applications for listing of the Equity Shares of our Company in one or more stock exchange(s) and to execute and to deliver or arrange the delivery of the listing agreement(s), or equivalent documentation to the concerned stock exchange(s) and to take all such actions as may be necessary in connection with obtaining the listing of the Equity Shares of our Company;
-
to make and approve amendments to the memorandum of association and the articles of association of our Company;
-
to approve all actions required to dematerialize the Equity Shares of our Company;
-
to approve codes of conduct as may be considered necessary by the Board or the IPO Committee or as required under applicable laws, regulations or guidelines for the Board, officers of our Company and other employees of our Company;
-
to approve a suitable policy on insider trading as required under applicable laws, regulations and guidelines;
-
to approve any corporate governance requirement that may be considered necessary by the Board or the IPO Committee or as may be required under applicable laws, regulations or guidelines in connection with the IPO;
-
to take all action as may be necessary or authorized in connection with any offer for sale;
-
to remunerate all book running lead managers, co-mangers to the Issue, underwriters to the Issue, bankers to our Company, syndicate members to the Issue, advisors to the Issue, stabilizing agent, brokers to the Issue, escrow collection bankers, accountants, auditors, depositories, trustees, custodians, registrar to the Issue, legal advisors as to Indian and overseas jurisdictions to our Company, advertising and/or promotion or public relations agencies and any other agencies, persons or other intermediaries as may be involved with the IPO, by way of commission, brokerage, fees or the like;
-
to seek the admission of our Company’s Equity Shares into the Central Depository Services (India) Limited and the National Securities Depository Limited and take any further action as may be necessary or required for the dematerialization of our Company’s Equity Shares;
-
to seek, if required, the consent of our Company’s lenders, parties with whom our Company has entered into various commercial and other agreements, all concerned government and regulatory authorities in India or outside India, and any other consents that may be required in connection with the IPO;
-
to determine the price band for the purpose of bidding, any revision to the price band and the final IPO price after bid closure;
-
to determine the bid opening and closing dates
-
to finalize the allocation/allotment/transfer of Equity Shares to retail investors/non-institutional investors/qualified institutional buyers in consultation with the book running lead managers, the stock exchanges and/or any other entity;
-
to allocate/issue/allot/transfer the Equity Shares in accordance with the terms of the IPO, and all such Equity Shares shall rank pari passu with the existing Equity Shares of our Company in all respects, except as may be provided under the terms of the Issue and any IPO document;
-
to authorize and empower Mr. Kannan K. Vishwanath, Mr. Kashi Vishwanathan and Mr. Prabhat K. Goyal, officers of our Company (each, an “Authorized Officer”), for and on behalf of our Company, to execute and deliver, on a several basis, any agreements and arrangements as well as amendments or supplements thereto that the Authorized Officer considers necessary, desirable or advisable, in connection with the IPO, including, without limitation, engagement letter(s), the listing agreements, the registrar’s agreement and memorandum of understanding, the depositories agreements, the memorandum of understanding with the book running lead managers (and other entities as appropriate), the underwriting agreement, the syndicate agreement, the stabilization agreement, the escrow agreement, confirmation of allocation notes, and any agreement or document in connection with the pre-IPO placement (including any placement agreement, escrow agreement and offering documentation), with the book running lead managers, co-mangers to the Issue, underwriters to the Issue, bankers to our Company, syndicate members to the Issue, advisors to the Issue, stabilizing agent, brokers to the Issue, escrow collection bankers, accountants, auditors, depositories, trustees, custodians, registrar to the Issue, legal advisors as to Indian and overseas jurisdictions to our Company, advertising and/or promotion or public relations agencies and any other agencies, persons or other intermediaries as may be involved with the IPO, and any such agreements or documents so executed and delivered and acts and things done by any such Authorized Officer shall be conclusive evidence of the authority of the Authorized Officer and our Company in so doing;
-
to severally authorize each of the Authorized Officers to enter into and execute all other arrangements, letters, agreements, deeds, and powers of attorney with the placement agents, and any such documents so executed and delivered or acts and things done by any Authorized Officer shall be conclusive evidence of the authority of such Authorized Officer and our Company in so doing and any document so executed and delivered or acts and things done by any such Authorized Officer prior to the date hereof are hereby ratified, confirmed and approved as the acts and deeds of the Authorized Officer and Company;
-
to make or to authorize an Authorized Officer to make any application and take any and all action in connection with obtaining approvals or entering into any arrangement, in respect thereof from the Foreign Investment Promotion Board of India, the Reserve Bank of India, the shareholders of our Company, the Government of India, the Securities and Exchange Board of India, the Registrar of Companies and such other authorities, as may be required, for the purpose of issue of the Equity Shares by our Company in the IPO, including the issue of the Equity Shares to non-resident investors, including but not limited to, NRIs, FIIs, FVCI’s and other non-residents;
-
to severally authorize and empower each Authorized Officer, for and on behalf of our Company, to execute and deliver any and all other documents, papers or instruments and to do or cause to be done any and all acts or things as any such Authorized Officer may deem necessary, appropriate or advisable in order to carry out the purposes and intent of the foregoing resolutions the IPO; and any such documents so executed and delivered or acts and things done by any such Authorized Officer shall be conclusive evidence of the authority of such Authorized Officer and our Company in so doing and any such document so executed and delivered or acts and things done by any such Authorized Officer prior to the date hereof are hereby ratified, confirmed and approved as the act and deed of the Authorized Officer and our Company, as the case may be;
-
to settle all questions, difficulties or doubts that may arise in regard to the Issue or allotment of Equity Shares as the IPO Committee may, in its absolute discretion, deem fit; and
-
to sign, execute, and deliver all such documents or instruments and do all such acts, deeds, matters and things as the IPO Committee may, in its absolute discretion, deem necessary or desirable in order to carry out the purposes and intent of the foregoing, or otherwise in relation to the Issue or any matter incidental or ancillary in relation to the Issue, including without limitation, allocation and allotment of the Equity Shares as permissible in law and issue of share certificates in accordance with the relevant rules, and any documents or instruments so executed and delivered or acts and things done or caused to be done by the IPO Committee shall be conclusive evidence of the authority of the IPO Committee in so doing.
|
| Policy On Disclosures And Internal Procedure For Prevention Of Insider Trading |
| |
We will comply with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 1992 after listing of our Company’s Equity Shares on the Stock Exchanges i.e. BSE and NSE.
Mr. Yogesh Patel, our Company Secretary and Compliance Officer, is responsible for setting forth policies, procedures, monitoring and adhering to the rules for the prevention of dissemination of price sensitive information and the implementation of the code of conduct under the overall supervision of the Board. |
| |
| Corporate Governance Reports |
| |
|
 |
|
 |
|
| |
|
 |
|
|
|
|
|
|